BioMaxima from the beginning of its activity focuses on production of reagents for clinical chemistry. For over 15 years, we have been improving our products and adapting them to the changing diagnostic market. We offer over 140 different biochemical reagents and controls including lines dedicated to the BM 100, BM 200 and BM 500 analyzers.
One of the latest challenges posed by the company's management was the development and production of our own BM 200 biochemical analyzer, which premiered in 2017.
BioMaxima was the first in Poland to start production of rapid diagnostic tests. The most popular and flagship product is the fecal occult blood test used for the diagnosis of colorectal cancer. We offer tests for infectious diseases, inflammatory and cancer markers and addictive drugs. Every year, based on the requirements of customers, we are expanding our offer with new diagnostic tests.